Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Projected Compound Annual Growth Rate (CAGR) of the Endocrine Testing Market from 2025 to 2034, and What Factors Influence It?

In recent times, the endocrine testing market has experienced significant expansion. The progression from $2.55 billion in 2024 to $2.8 billion in 2025 indicates a compound annual growth rate (CAGR) of about 9.8%. Factors that contributed to such growth during this historic period include the discovery of hormones and endocrine pathways, standardization of diagnostic tests, initiatives towards public health, along with empowerment and advocacy of patients.

Expectations are high that the size of the endocrine testing market will witness robust growth in the upcoming years. It’s predicted to expand to $4.01 billion by 2029, with a compound annual growth rate (CAGR) of 9.5%. Factors contributing to the growth during the forecast period include the rising incidence of endocrine disorders, an uptick in defense spending, an aging demographic, and heightened awareness leading to early diagnosis. Key trends anticipated during the forecast period encompass advancements in the detection of biomarkers, incorporation of omics technologies, the deployment of artificial intelligence and machine learning, quality assurance and standardization efforts, along with collaborative research and translation medicine.

How Are the key drivers Contributing to the Expansion of the Endocrine Testing Market?

The escalating incidence of diabetes is projected to spur the expansion of the endocrine testing market. Essentially, diabetes is a collection of disorders that lead to elevated levels of blood sugar (glucose). The growth in the incidence of diabetes is attributed to factors like unhealthy eating habits, lack of physical activity, hereditary factors, and an aging demographic. Endocrine testing, encompassing tests like hemoglobin A1c, fasting plasma glucose, and C-peptide, is employed in the diagnosis and monitoring of diabetes, as well as in evaluating insulin production and sensitivity. For example, data from the National Health Service (NHS), a UK government department, suggest a substantial increase in the number of individuals under 40 suffering from this disease, from 173,166 in 2022 to 216,440 in 2023. This substantial growth underlines a concerning pattern in this demographic, indicating a swift rise in diabetes incidence among younger age groups. Consequently, this surge in diabetes incidence is fueling the endocrine testing market.

Explore Comprehensive Insights Into The Global Endocrine Testing Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15562&type=smp

Who Are the Leading Players Fueling Growth in the Endocrine Testing Market?

Major companies operating in the endocrine testing market are:

• Zebra Technologies Corporation_x000D_

• HPE Aruba Networking_x000D_

• Cisco Meraki_x000D_

• Geotab Inc._x000D_

• DecaWave Limited_x000D_

What Are the Emerging Trends Shaping the Future of the Endocrine Testing Market?

Leading firms in the endocrine testing market are forging ahead with the development of point-of-care testing solutions to uplift efficiency and accessibility of endocrine disorder diagnosis. Expedient results attained from point-of-care testing can catalyze the process of diagnosing and managing heart failure in patients displaying symptoms alike fatigue and shortness of breath. For example, Roche Holding AG, a pharmaceutical company based in Switzerland, in April 2024, unveiled a point-of-care NT-proBNP test in India. This test was particularly designed to screen diabetes patients susceptible to cardiovascular diseases including heart failure (HF). It empowers early detection and subsequent intervention, providing clinicians with the capacity to pinpoint high-risk T2D patients and embark on relevant treatment discussions promptly. This test encourages early detection and action, enabling health care providers to identify T2D patients at high risk and begin vital treatment dialogues, ultimately fostering better results and patient health.

Secure Your Global Endocrine Testing Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/endocrine-testing-global-market-report

What Are the Main Segments of the Endocrine Testing Market, and How Are They Evolving?

The endocrine testing market covered in this report is segmented –

1) By Test Type: Estradiol (E2) Test, Follicle Stimulating Hormone (FSH) Test, Human Chorionic Gonadotropin (hCG) Hormone Test, Luteinizing Hormone (LH) Test, Dehydroepiandrosterone Sulfate (DHEAS) Test, Progesterone Test, Testosterone Test, Thyroid Stimulating Hormone (TSH) Test, Prolactin Test, Other Types

2) By Technology: Tandem Mass Spectrometry, Immunoassay, Monoclonal And Polyclonal Antibody Technologies, Sensor Technology, Clinical Chemistry, Other Technologies

3) By End-User: Hospitals, Clinical Laboratories, Diagnostic Centers, Other End-Users

Subsegments:

1) By Estradiol (E2) Test: Serum Estradiol Test, Urinary Estradiol Test

2) By Follicle Stimulating Hormone (FSH) Test: FSH Serum Test, FSH Urine Test

3) By Human Chorionic Gonadotropin (hCG) Hormone Test: Quantitative hCG Test, Qualitative hCG Test

4) By Luteinizing Hormone (LH) Test: LH Serum Test, LH Urine Test

5) By Dehydroepiandrosterone Sulfate (DHEAS) Test: Serum DHEAS Test, Saliva DHEAS Test

6) By Progesterone Test: Serum Progesterone Test, Urinary Progesterone Test

7) By Testosterone Test: Free Testosterone Test, Total Testosterone Test

8) By Thyroid Stimulating Hormone (TSH) Test: TSH Serum Test, TSH Saliva Test

9) By Prolactin Test: Serum Prolactin Test, Plasma Prolactin Test

10) By Other Types: Cortisol Test, Insulin Test, Growth Hormone (GH) Test, Aldosterone Test

Which Regions Are Driving Growth in the Endocrine Testing Market?

North America was the largest region in the endocrine testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endocrine testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Endocrine Testing Market Defined Across Different Regions?

Endocrine testing refers to the diagnostic process of evaluating hormone levels in the body, typically through blood, urine, or saliva tests, to assess the function of the endocrine system. These tests are crucial for diagnosing various endocrine disorders, including diabetes, thyroid disorders, adrenal insufficiency, and pituitary gland disorders. Endocrine testing helps healthcare providers determine the appropriate treatment and management plans for patients with these conditions.

Browse Through More Similar Reports By The Business Research Company:

Peptide Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

C-Reactive Protein Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/c-reactive-protein-testing-global-market-report

Food Safety Testing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/food-safety-testing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: